Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Journal for Immunotherapy of Cancer|October 9, 2025
Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapyPaolo Strati, Amanda Brandt, Anath C Lionel, et al.
Clinical and Translational Radiation Oncology|May 23, 2022
Second malignancies in patients with Hodgkin's Lymphoma: Half a century of experienceBouthaina Shbib Dabaja, David Boyce-Fappiano, Wenli Dong, et al.
Blood Cancer Journal|August 28, 2020
Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different featuresWen Shuai, Pei Lin, Paolo Strati, et al.
The Lancet. Haematology|July 3, 2025
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 studyPaolo Strati, Januario Castro, Aaron Goodman, et al.
Blood Advances|March 3, 2022
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapySushanth Gouni, Allison C Rosenthal, Jennifer L Crombie, et al.
Ejhaem|September 1, 2020
Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?Jillian R Gunther, Chelsea C Pinnix, Gordon R Glober, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2017
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOPPaolo Strati, Nathan Fowler, Sergio Pina-Oviedo, et al.
Blood Advances|May 12, 2019
Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLLPaolo Strati, Koichi Takahashi, Christine B Peterson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2020
A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) LymphomaPenny Fang, Jillian R Gunther, Chelsea C Pinnix, et al.
Lancet (London, England)|January 11, 2025
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trialArmin Ghobadi, Veronika Bachanova, Krish Patel, et al.
Pageof 16